Cargando…
Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We asse...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970441/ https://www.ncbi.nlm.nih.gov/pubmed/29801506 http://dx.doi.org/10.1186/s12931-018-0808-x |
_version_ | 1783326128919805952 |
---|---|
author | Szentes, Boglárka Lilla Kreuter, Michael Bahmer, Thomas Birring, Surinder S. Claussen, Martin Waelscher, Julia Leidl, Reiner Schwarzkopf, Larissa |
author_facet | Szentes, Boglárka Lilla Kreuter, Michael Bahmer, Thomas Birring, Surinder S. Claussen, Martin Waelscher, Julia Leidl, Reiner Schwarzkopf, Larissa |
author_sort | Szentes, Boglárka Lilla |
collection | PubMed |
description | BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We assessed disease-specific (K-BILD) and generic HRQL (EQ-5D experience based value set (EBVS) and Visual Analog Scale (VAS)) in 229 patients with different ILD subtypes in a longitudinal observational study (HILDA). Additionally, we assessed the correlation of the HRQL measures with lung function and comorbidities. In a linear regression model, we investigated predictors (including age, sex, ILD subtype, FVC percentage of predicted value (FVC%pred), DLCO percentage of predicted value, and comorbidities). RESULTS: Among the 229 patients mean age was 63.2 (Standard deviation (SD): 12.9), 67.3% male, 24.0% had idiopathic pulmonary fibrosis, and 22.3% sarcoidosis. Means scores were as follows for EQ-5D EBVS 0.66(SD 0.17), VAS 61.4 (SD 19.1) and K-BILD Total 53.6 (SD 13.8). K-BILD had good construct validity (high correlation with EQ-5D EBVS (0.71)) and good internal consistency (Cronbach’s alpha 0.89). Moreover, all HRQL measures were highly accepted by patients including low missing items and there were no ceiling or floor effects. A higher FVC % pred was associated with higher HRQL in all measures meanwhile comorbidities had a negative influence on HRQL. CONCLUSIONS: K-BILD and EQ-5D had similar HRQL trends and were associated similarly to the same disease-related factors in Germany. Our data supports the use of K-BILD in clinical practice in Germany, since it captures disease specific effects of ILD. Additionally, the use of the EQ-5D-5L could provide comparison to different disease areas and give an overview about the position of ILD patients in comparison to general population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0808-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5970441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59704412018-05-30 Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L Szentes, Boglárka Lilla Kreuter, Michael Bahmer, Thomas Birring, Surinder S. Claussen, Martin Waelscher, Julia Leidl, Reiner Schwarzkopf, Larissa Respir Res Research BACKGROUND: Patients with interstitial lung diseases (ILD) have impaired health-related quality of life (HRQL). Little is known about the applicability of the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) and the generic EQ-5D-5L in a German setting. METHODS: We assessed disease-specific (K-BILD) and generic HRQL (EQ-5D experience based value set (EBVS) and Visual Analog Scale (VAS)) in 229 patients with different ILD subtypes in a longitudinal observational study (HILDA). Additionally, we assessed the correlation of the HRQL measures with lung function and comorbidities. In a linear regression model, we investigated predictors (including age, sex, ILD subtype, FVC percentage of predicted value (FVC%pred), DLCO percentage of predicted value, and comorbidities). RESULTS: Among the 229 patients mean age was 63.2 (Standard deviation (SD): 12.9), 67.3% male, 24.0% had idiopathic pulmonary fibrosis, and 22.3% sarcoidosis. Means scores were as follows for EQ-5D EBVS 0.66(SD 0.17), VAS 61.4 (SD 19.1) and K-BILD Total 53.6 (SD 13.8). K-BILD had good construct validity (high correlation with EQ-5D EBVS (0.71)) and good internal consistency (Cronbach’s alpha 0.89). Moreover, all HRQL measures were highly accepted by patients including low missing items and there were no ceiling or floor effects. A higher FVC % pred was associated with higher HRQL in all measures meanwhile comorbidities had a negative influence on HRQL. CONCLUSIONS: K-BILD and EQ-5D had similar HRQL trends and were associated similarly to the same disease-related factors in Germany. Our data supports the use of K-BILD in clinical practice in Germany, since it captures disease specific effects of ILD. Additionally, the use of the EQ-5D-5L could provide comparison to different disease areas and give an overview about the position of ILD patients in comparison to general population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0808-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-25 2018 /pmc/articles/PMC5970441/ /pubmed/29801506 http://dx.doi.org/10.1186/s12931-018-0808-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Szentes, Boglárka Lilla Kreuter, Michael Bahmer, Thomas Birring, Surinder S. Claussen, Martin Waelscher, Julia Leidl, Reiner Schwarzkopf, Larissa Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title | Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title_full | Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title_fullStr | Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title_full_unstemmed | Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title_short | Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L |
title_sort | quality of life assessment in interstitial lung diseases:a comparison of the disease-specific k-bild with the generic eq-5d-5l |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970441/ https://www.ncbi.nlm.nih.gov/pubmed/29801506 http://dx.doi.org/10.1186/s12931-018-0808-x |
work_keys_str_mv | AT szentesboglarkalilla qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT kreutermichael qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT bahmerthomas qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT birringsurinders qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT claussenmartin qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT waelscherjulia qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT leidlreiner qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l AT schwarzkopflarissa qualityoflifeassessmentininterstitiallungdiseasesacomparisonofthediseasespecifickbildwiththegenericeq5d5l |